Jan 30, 2025

Suitable for standard injection molding machinery, Smartbatch™ FX reduced the cost per part by 30 percent or more compared to painted parts.

Jan 30, 2025

EPS: $2.50 Assumptions • Operating margins in mid-range of 2015 targets • No global recession • No investment in incremental PP&S capacity • Completion of 2-3 midsize accretive acquisitions • Housing starts at 85% of 50 year norm by 2015 • Mid single digit revenue CAGR • Remain comfortably below 3X Net Debt / EBITDA Page 11 2012 Rev: $2.9B Adj. EPS: $1.00 $0.54 $0.68 $0.30 $0.45 $0.60 $0.75 H1'12 H1'13 Adjusted EPS $101.0 $132.6 $50.0 $100.0 $150.0 H1'12 H1'13 Adjusted Operating Income (millions) +31% $68.6 $97.7 $50.0 $75.0 $100.0 H1'12 H1'13 Specialty Operating Income (millions) First Half 2013 Financial Highlights • Adjusted EPS increased 26% over prior year first half • Operating Income expanded 31% versus first half 2012 • Specialty operating income up 42% • Revenue grew 22% versus 1H ‘12 • Portfolio transformation activities  Completed acquisition of Spartech  Divested non-core Resin business +26% +42% Page 12 • Significant Debt Maturities $ 1,010 Other Debt 21 • Total Debt at 6/30/13 Less: Cash Net Debt • Available Liquidity Cash ABL Availability Total Liquidity • Net Debt / EBITDA = 1.9x • Net Debt / EBITDA = 2.1x*(tax adjusted) $392 310 $702 $1,031 392 $639 $50 $360 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Significant Debt Maturities As of June 30, 2013 ($ millions) Page 13 Coupon Rates: 7.500% 7.375% 5.250% *Pro Forma TTM for taxes on resin gain Debt Maturities & Liquidity Summary – 6/30/13 Cash Balance = $392M Net Debt / EBITDA* = 1.9x • Repurchased ~3.0M shares YTD in 2013 • 17 million shares are available for repurchase under the current authorization Share Repurchase • Introduced a quarterly dividend in Q1 2011 and increased in Q1 2012 (25%) and Q1 2013 (20%) • Objective of maintaining and growing Dividends • Expanding our sales, marketing, and technical capabilities is top priority • Investing in operational and LSS initiatives (including synergy capture) • CAPEX Organic Growth • Targets that expand our: • Specialty offering • End market presence • Geographic footprint • Synergy opportunities • Adjacent material solutions • North American manufacturing alignment Acquisitions *TTM 6/30/2013 Use of Cash Page 14 Why Invest In PolyOne? Net debt $ 638.8 Adjusted EBITDA Q3 2012 Q4 2012 Q1 2013 Q2 2013 Total PolyOne Income before income taxes $ 30.6 $ (1.1) $ 15.7 $ 62.9 $ 108.1 PolyOne Interest expense, net 12.4 13.7 15.6 16.6 58.3 PolyOne Depreciation and amortization 17.0 15.5 19.0 25.8 77.3 PolyOne Special items in EBITDA 8.3 26.5 27.7 (5.2) 57.3 PolyOne Adjusted EBITDA 68.3 54.6 78.0 100.1 301.0 Pro forma Spartech EBITDA 16.8 14.7 11.2 - 42.7 Pro forma EBITDA $ 85.1 $ 69.3 $ 89.2 $ 100.1 $ 343.7 PolyOne Investor Presentation�Credit Suisse 26th Annual Chemical and Ag Science Conference��September 17th, 2013� Forward – Looking Statements Use of Non-GAAP Measures Strategy and Execution Drive Results Four Pillar Strategy PolyOne�At A Glance Mix Shift Highlights Specialty Transformation Proof of Performance & 2015 Goals Innovation Drives Earnings Growth We are Experts in Polymer Science and Formulation Positioned for Strong Growth First Half 2013 Financial Highlights Debt Maturities & Liquidity Summary – 6/30/13 Use of Cash Why Invest In PolyOne?

EPS: $2.50 Assumptions • Operating margins in mid-range of 2015 targets • No global recession • No investment in incremental PP&S capacity • Completion of 2-3 midsize accretive acquisitions • Housing starts at 85% of 50 year norm by 2015 • Mid single digit revenue CAGR • Remain comfortably below 3X Net Debt / EBITDA Page 11 2012 Rev: $2.9B Adj. EPS: $1.00 $0.54 $0.68 $0.30 $0.45 $0.60 $0.75 H1'12 H1'13 Adjusted EPS $101.0 $132.6 $50.0 $100.0 $150.0 H1'12 H1'13 Adjusted Operating Income (millions) +31% $68.8 $97.7 $50.0 $75.0 $100.0 H1'12 H1'13 Specialty Operating Income (millions) First Half 2013 Financial Highlights • Adjusted EPS increased 26% over prior year first half • Operating Income expanded 31% versus first half 2012 • Specialty operating income up 42% • Revenue grew 22% versus 1H ‘12 • Portfolio transformation activities  Completed acquisition of Spartech  Divested non-core Resin business +26% +42% Page 12 • Significant Debt Maturities $ 1,010 Other Debt 21 • Total Debt at 6/30/13 Less: Cash Net Debt • Available Liquidity Cash ABL Availability Total Liquidity • Net Debt / EBITDA = 1.9x* • Net Debt / EBITDA = 2.1x*(tax adjusted) $392 310 $702 $1,031 392 $639 $50 $360 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Significant Debt Maturities As of June 30, 2013 ($ millions) Page 13 Coupon Rates: 7.500% 7.375% 5.250% *Pro Forma TTM Debt Maturities & Liquidity Summary – 6/30/13 Cash Balance = $392M Net Debt / EBITDA* = 1.9x • Repurchased ~3.0M shares YTD in 2013 • 17 million shares are available for repurchase under the current authorization Share Repurchase • Introduced a quarterly dividend in Q1 2011 and increased in Q1 2012 (25%) and Q1 2013 (20%) • Objective of maintaining and growing Dividends • Expanding our sales, marketing, and technical capabilities is top priority • Investing in operational and LSS initiatives (including synergy capture) • CAPEX Organic Growth • Targets that expand our: • Specialty offering • End market presence • Geographic footprint • Synergy opportunities • Adjacent material solutions • North American manufacturing alignment Acquisitions *TTM 6/30/2013 Use of Cash Page 14 Why Invest In PolyOne? Net debt $ 638.8 Adjusted EBITDA Q3 2012 Q4 2012 Q1 2013 Q2 2013 Total PolyOne Income before income taxes $ 30.6 $ (1.1) $ 15.7 $ 62.9 $ 108.1 PolyOne Interest expense, net 12.4 13.7 15.6 16.6 58.3 PolyOne Depreciation and amortization 17.0 15.5 19.0 25.8 77.3 PolyOne Special items in EBITDA 8.3 26.5 27.7 (5.2) 57.3 PolyOne Adjusted EBITDA 68.3 54.6 78.0 100.1 301.0 Pro forma Spartech EBITDA 16.8 14.7 11.2 - 42.7 Pro forma EBITDA $ 85.1 $ 69.3 $ 89.2 $ 100.1 $ 343.7 PolyOne Investor Presentation�Jefferies 2013 Global Industrials Conference��August 13, 2013� Forward – Looking Statements Use of Non GAAP Measures Strategy and Execution Drive Results Four Pillar Strategy PolyOne�At A Glance Mix Shift Highlights Specialty Transformation Proof of Performance & 2015 Goals Innovation Drives Earnings Growth We are Experts in Polymer Science and Formulation Positioned for Strong Growth First Half 2013 Financial Highlights Debt Maturities & Liquidity Summary – 6/30/13 Use of Cash Why Invest In PolyOne?

Available in four overmolding grades compatible with polypropylene (PP), and one grade that is suited for overmolding onto ABS, all grades are formulated for durability, delivering property retention and UV resistance comparable to traditional TPEs. Peel (N/mm) 3.2 2.9 3.2 3.2 3.1 3.2 3.1 Failure Mode Cohesive Cohesive Cohesive Cohesive Cohesive Cohesive Cohesive KEY PROPERTIES AND OVERMOLD PERFORMANCE reSound™ OM 5510 grades for overmolding onto PP and reSound OM 5520 for ABS reSound OM 5510-30N reSound OM 5510-45N reSound OM 5510-60N reSound OM 5510-70N reSound OM 5520-55N Bio-derived Content (%) 40% 40% 50% 50% 49% Hardness, Shore A 30 45 60 70 54 Specific Gravity 0.88 0.88 0.89 0.89 0.95 50% Modulus, PSI 96 153 247 384 258 100% Modulus, PSI 137 251 343 462 353 Tensile Strength, PSI 264 438 625 608 637 Elongation, % 280 215 306 271 319 Tear Strength, PLI 58 84 109 132 146 OM Substrate PP PP PP PP ABS OM Avg. Peel, PLI 12 19 23 20 19 reSound OM 5510 for PP reSound OM 5510-60N Room Temperature 70C 1 day 1 week 2 weeks 6 months 1 week 2 weeks 3 weeks Bio-derived Content (%) 50% 50% 50% 50% 50% 50% 50% Hardness, Shore A 60 60 60 60 60 60 60 Specific Gravity 0.89 0.89 0.89 0.89 0.89 0.89 0.90 50% Modulus, PSI 247 241 244 251 234 244 240 100% Modulus, PSI 343 333 338 339 321 331 326 Tensile Strength, PSI 625 621 647 610 633 662 642 Elongation, % 306 314 309 313 312 315 315 Tear Strength, PLI 109 108 113 113 111 117 115 reSound OM 5520-55N Room Temperature 70C 1 day 1 week 2 weeks 6 months 1 week 2 weeks 3 weeks Bio-derived Content (%) 49% 49% 49% 49% 49% 49% 49% Hardness, Shore A 54 54 55 55 54 55 56 Specific Gravity 0.95 0.95 0.96 0.96 0.95 0.96 0.96 50% Modulus, PSI 258 256 256 265 266 271 257 100% Modulus, PSI 353 355 357 362 373 379 367 Tensile strength, PSI 637 615 637 669 651 674 642 Elongation, % 319 315 319 333 313 319 315 Tear Strength, PLI 146 136 133 142 137 138 141 reSound OM 5510-45N Room Temperature 70C 1 day 1 week 2 weeks 6 months 1 week 2 weeks 3 weeks Bio-derived Content (%) 40% 40% 40% 40% 40% 40% 40% Hardness, Shore A 45 46 47 46 46 45 45 Specific Gravity 0.88 0.89 0.89 0.89 0.89 0.89 0.90 50% Modulus, PSI 153 158 154 162 137 136 133 100% Modulus, PSI 251 259 259 261 226 222 218 Tensile Strength, PSI 438 481 451 495 417 470 486 Elongation, % 215 240 211 243 204 227 238 Tear Strength, PLI 84 81 87 82 83 85 84 AGING – PROPERTY RETENTION • Tested at room temperature and 70° C for comparison • Hardness, tensile strength elongation and modulus showed great retention Overmolding onto PP Overmolding onto ABS RHEOLOGY Suitable for injection molding and overmolding 1.0 10 100 1000 10000 100000 10.0 100.0 1000.0 reSound OM 5510-30N reSound OM 5510-45N reSound OM 5510-60N reSound OM 5510-70N Shear Rate, 1/s Ca pi lla ry V is co si ty , P a* s 1.0 10 100 1000 10000 100000 10.0 100.0 1000.0 reSound OM 5520-55N Shear Rate, 1/s Ca pi lla ry V is co si ty , P a* s Capillary viscosity at 200°C Capillary viscosity at 200°C reSound OM 5510 for PP reSound OM 5520 for ABS www.avient.com Copyright © 2020, Avient Corporation.

VersaflexTM PF Versaflex PF VOC Versaflex PF VERSAFLEX PF VOC 39 LDPE / 13 Versaflex PF VERSAFLEX PF 39 LDPE / 13 Versaflex PF N /2 5 m m N /2 5 m m F = 25 ° C 7 I = 25 ° C 20 MD6741 / MD6700 VERSAFLEX PFTM +86 021 60284888 www.avient.com VERSAFLEX™ PF 1 CF6751 PP 2 2420K LDPE Versaflex™ PF MD6727 Versaflex™ PF MD6741 Versaflex™ CF 6751 Versaflex™ PF MD6649 Versaflex™ PF 9512 Versaflex™ CF 8888N-A Versaflex™ PF MD6666 Versaflex™ PF MD6748 Versaflex™ PF MD6700 Versaflex™ CF 9000 PP PVC Tg (°C) -26 -43 -30 -26 -5 1 -6 0 5 / (Shore A) 50 49 35 37 38 35 37 31 30 19 MFI (190°C, 2.16kg) (g/10min) / / / 15 5 15 20 3 5 27 MFI (230°C, 2.16kg) 8 20 8 / / / / / / / 1 LDPE 2420k2/LDPE 2420k/Versaflex™ =4.5/4.5/1 ; =50um (N/25mm) 25°C 20 1.3 1.8 7.9 2.5 2.2 2.7 3.3 3.0 3.7 4.3 75°C 7 5.7 2.9 7.2 3.1 4.0 4.3 4.3 5.5 5.6 / PMMA (N/25mm) 25°C 20 1.8 2.0 7.2 2.6 2.8 3.0 3.6 3.3 3.9 4.9 75°C 7 5.5 4.7 7.1 3.5 / 4.7 6.5 5.8 6.9 /

FDA/EU compliance information available upon request REMAFIN™ EP White Colorants for Pharmaceutical Packaging REMAFIN™ EP is a range of PE and PP based masterbatches designed for protecting oral, topical, parenteral, ophthalmic and nasal pharmaceuticals by opacifying primary and secondarypharmaceutical packaging. KEY CHARACTERISTICS • Manufactured under change control principles beyond CAS number (similar level as MEVOPUR concentrates), reducing risk of change • Free from animal-derived substances and phthalates • Suitable for blown film, injection molding, blow molding and extrusion REGULATORY SUPPORT • Raw materials tested to: - ISO 10993-1 - USP chapters , including Class VI, a requirement for ophthalmic and nasal drugs - European Pharmacopeia 3.1.3/3.1.5 (polyolefin) - USP (polyethylene) - ICH Q3D elemental impurities - USP and USP light transmission • Registered Drug Master File (Type III) • Food contact compliance established with FDA/EU* APPLICATION BULLETIN CARRIER MATERIAL PIGMENT CONTENT/TYPE LIGHT FASTNESS THERMAL STABILITY PRODUCT CODE HDPE 50% TiO2 8 300°C PH00075525 LLDPE 60% TiO2 8 300°C PL00075542 LLDPE 70% TiO2 8 300°C PL00075545 PP 50% TiO2 8 300°C PP00075717 Healthcare use limitations apply—see below. Without limiting the generality of this statement, Avient products shall not be used in any medical device application intended for: (1) exposure to human tissue or body fluids for 30 days or greater; (2) “plastic” (cosmetic or reconstructive) surgery use; (3) reproductive implants or any birth control device; or (4) any critical component in a permanently (greater than 30 days) implanted medical device that supports or sustains human life.

In fact, case studies have shown scrap rates can be reduced from 30% to less than 1%. PP, PE, PS, PVC No Good Foam PP Better, larger cells with lower cell density in standard IM processes; suitable for cell nucleation in structural foam processing PP, PE, PS, PVC Yes Better FA-110 Best cell structure with higher cell density; provides better structural integrity and lower density in standard IM processes PP, PE, PS, PVC Yes Best KEY CHARACTERISTICS Excelite IM formulations provide injection molders with: • Material density and weight reduction • High concentration of active CFA • Improved distribution of CFA into polymer matrix • High cell density with tight cell structure • Control over consistency and accuracy • Reduced sink marks • Ability to improve flow of material • Cycle time reduction • Improved dimensional stability • Improved thermal insulation EXCELITE IM – PRODUCT FORMULATIONS www.avient.com Copyright © 2020, Avient Corporation.

Suitable for standard injection molding machinery, Smartbatch™ FX reduced the cost per part by 30 percent or more compared to painted parts.